Incidence and Development of Cholestasis in Surgical Neonates Receiving an Intravenous Mixed‐Oil Lipid Emulsion

Lumeng J. Yu,Lorenzo Anez‐Bustillos,Paul D. Mitchell,Victoria H. Ko,Jordan D. Secor, Alexis Potemkin Hurley,Duy T. Dao,Scott C. Fligor,Bennet S. Cho,Savas T. Tsikis,Kathleen M. Gura,Mark Puder

Journal of Parenteral and Enteral Nutrition（2022）

引用 4|浏览14

暂无评分

摘要

In surgical neonates, MOLE may not prevent cholestasis and should not be considered hepatoprotective. Regardless of ILE source, all surgical neonates should be closely monitored for development of IFALD. To date, there is still no ILE able to prevent IFALD.

查看译文

关键词

cholestasis,intestinal failure-associated liver disease,lipid emulsion,parenteral nutrition,surgical neonate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要